Investing In Vaccine Research, Innovation Critical To Achieving SDGs

Devex: Delivering the next generation of vaccines
Cécile Vernant, head of E.U. advocacy for Deutsche Stiftung Weltbevoelkerung

“…If we are serious about ending [malaria, HIV, TB, and other diseases of poverty] by 2030, then we will need new and innovative vaccines. … If we are to harness the latent potential in vaccine research, how are we to do it? 1. Sustainable and sufficient funding … 2. A coherent investment strategy … 3. Support for innovation across the development cycle … As we move into the next era of global development policy — the 2030 Agenda for Sustainable Development — we need to secure and build on this progress, to achieve breakthroughs in the fight against diseases such as HIV, TB, and malaria. Investing in research and innovation targeted at these diseases now and in the right policy environment could usher in the next revolution in immunization” (4/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.